Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Company news
Company news
ChemDiv Announces Multi-Year Hit Identification Collaboration with Janssen
SAN DIEGO, Jan.
ChemDiv Selected by Arcus Biosciences as the Sole Chemistry Provider for its Discovery Screening Collection
SAN DIEGO, CA, June 09, 2017 – ChemDiv Inc.
Regen BioPharma Begins Optimization of NR2F6 Small Molecule Modulators
SAN DIEGO, February 1, 2017 /PRNewswire/ --ChemDiv Inc.
ChemDiv Reaches Milestone in Viriom Collaboration
ChemDiv has reached a development milestone in partnership with Viriom Inc.
ChemDiv Announces Key Milestones in Abbott Pharma Collaboration
SAN DIEGO, Jan.
NewVac Reports Primary Endpoint Met in Phase II Clinical Trial of Quisinostat in Platinum-Resistant Ovarian Cancer
SAN DIEGO, Jan.
Viriom Announces Collaboration with NIH on Zika and Other Major Viral Diseases
SAN DIEGO, CA, USA I January 6, 2017 I Viriom Inc.
ChemDiv, Torrey Pines Investment and DZNE Announce Research Collaboration
SAN DIEGO, Oct.
New molecule may help fight obesity
Researchers, including one of Indian-origin, have identified a new molecule that may help fight obesity and other metabolic diseases by converting 'bad' fat to 'good' fat.
Trevi Therapeutics Announces Positive Results from Phase 2 Trial in Prurigo Nodularis
NEW HAVEN, CT, USA I October 13, 2016 I Trevi Therapeutics, Inc.
ChemDiv is presenting at the SCI's event: Innovation in Design, Supply and Acquisition for Compound Screening Libraries, on 14th September 2016 in Hatfield, UK
Dr.
ChemDiv and Insilico Medicine Form A Strategic Alliance to Develop Oncology Focused Libraries Using Artificial Intelligence
ChemDiv, Inc.
3
4
5
6
7
8
